Flomics — Seed · €1.1M

A US family office that was not named led this €1.1M (about $1.2M) round, with Decelera Ventures I FCR, Histemi Inversiones and the Dr. Rosell Oncology Institute (IOR) taking part. The money goes to preclinical validation of the company's RNA liquid-biopsy test for five cancers. GenomeWeb calls it a seed round and some Spanish coverage calls it a Series A.